Molecular structure of (+)-Butaclamol hydrochloride, CAS Number: 55528-07-9
(+)-Butaclamol hydrochloride (CAS 55528-07-9)
Application:
(+)-Butaclamol hydrochloride is a D2DR inhibitor
CAS Number:
55528-07-9
Molecular Weight:
397.98
Molecular Formula:
C25H31NO•HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
(+)-Butaclamol hydrochloride is a D2DR inhibitor. Studies on rat striatal Homovanillic acid (sc-204002) concentrations indicate that (+)-Butaclamol hydrochloride increases the concentration of this compound, via D2DR antagonism. In addition, these studies concluded that (+)-Butaclamol hydrochloride is 2 to 4 times more active than its enantiomer at inhibiting the D2DR. Alternate studies indicate that (+)-Butaclamol hydrochloride is more effective in the presence of GDP. Furthermore, it is suggested that (+)-Butaclamol hydrochloride acts as an inverse agonist of the D2DR by stabilizing the uncoupled form of the receptor.
(+)-Butaclamol hydrochloride (CAS 55528-07-9) References
- Effect of structural analogs of butaclamol (a new antipsychotic drug) on striatal homovanillic acid and adenyl cyclase of olfactory tubercle in rats. | Pugsley, TA., et al. 1976. Can J Physiol Pharmacol. 54: 510-5. PMID: 10057
- Mechanisms of inverse agonist action at D2 dopamine receptors. | Roberts, DJ. and Strange, PG. 2005. Br J Pharmacol. 145: 34-42. PMID: 15735658
- Imaging analysis of clock neurons reveals light buffers the wake-promoting effect of dopamine. | Shang, Y., et al. 2011. Nat Neurosci. 14: 889-95. PMID: 21685918
- A 'genome-to-lead' approach for insecticide discovery: pharmacological characterization and screening of Aedes aegypti D(1)-like dopamine receptors. | Meyer, JM., et al. 2012. PLoS Negl Trop Dis. 6: e1478. PMID: 22292096
- Neuromechanism study of insect-machine interface: flight control by neural electrical stimulation. | Zhao, H., et al. 2014. PLoS One. 9: e113012. PMID: 25409523
- Modification of Male Courtship Motivation by Olfactory Habituation via the GABAA Receptor in Drosophila melanogaster. | Tachibana, S., et al. 2015. PLoS One. 10: e0135186. PMID: 26252206
- The Ascaris suum nicotinic receptor, ACR-16, as a drug target: Four novel negative allosteric modulators from virtual screening. | Zheng, F., et al. 2016. Int J Parasitol Drugs Drug Resist. 6: 60-73. PMID: 27054065
- Examining the Effects of Sodium Ions on the Binding of Antagonists to Dopamine D2 and D3 Receptors. | Newton, CL., et al. 2016. PLoS One. 11: e0158808. PMID: 27379794
- Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs. | McCorvy, JD., et al. 2018. Nat Chem Biol. 14: 126-134. PMID: 29227473
- Brexpiprazole has a low risk of dopamine D2 receptor sensitization and inhibits rebound phenomena related to D2 and serotonin 5-HT2A receptors in rats. | Amada, N., et al. 2019. Neuropsychopharmacol Rep. 39: 279-288. PMID: 31487433
- A Mechanism Linking Two Known Vulnerability Factors for Alcohol Abuse: Heightened Alcohol Stimulation and Low Striatal Dopamine D2 Receptors. | Bocarsly, ME., et al. 2019. Cell Rep. 29: 1147-1163.e5. PMID: 31665630
- Screening for modulators of neural network activity in 3D human iPSC-derived cortical spheroids. | Woodruff, G., et al. 2020. PLoS One. 15: e0240991. PMID: 33091047
- A study of the dopamine transporter using the TRACT assay, a novel in vitro tool for solute carrier drug discovery. | Sijben, HJ., et al. 2021. Sci Rep. 11: 1312. PMID: 33446713
- Identification of novel target molecules of l-menthol. | Umezu, T. 2021. Heliyon. 7: e07329. PMID: 34195432
Inhibitor of:
D2DR, and DARPP-32.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
(+)-Butaclamol hydrochloride, 5 mg | sc-252525 | 5 mg | $129.00 |